GSK3B and schizophrenia: Furthermore, a systematic meta-analysis showed that rs334558, functional polymorphism in the GSK-3β promotor region, is associated with incidence of schizophrenia, and suggested that this SNP might be used for differential diagnosis between schizophrenia and bipolar disorder [128].